Garcia-Paramio P, Cabrerizo Y, Bornancin F, Parker P J
Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX, UK.
Biochem J. 1998 Aug 1;333 ( Pt 3)(Pt 3):631-6. doi: 10.1042/bj3330631.
Dominant negative properties are conferred on protein kinase (PK) Calpha by mutation of the phosphorylation site in the activation loop of the kinase domain. To address the universality and/or specificity of such mutations, analogous alterations were introduced in other members of the PKC family and tested for their effects on the function of co-transfected activated PKC. For all three subclasses of the PKC family, mutations of the predicted activation loop phosphorylation sites resulted in dominant negative properties. These properties were not restricted to the cognate PKC isotypes, but were effective across the different subclasses. For example, two PKCzeta mutants (atypical isotype) inhibited both PKCalpha (classical isotype) and PKCepsilon (novel isotype). For all these mutants, inhibition correlated with an ability to prevent the accumulation of phosphorylated PKCalpha, consistent with the expected mode of action. In the case of the PKCalpha mutant, it was shown that inhibition required the full-length mutant protein. The results provide evidence for the involvement of a common step in the phosphorylation of all PKC isotypes.
通过激酶结构域激活环中磷酸化位点的突变,赋予蛋白激酶(PK)Cα显性负性特性。为了探究此类突变的普遍性和/或特异性,在PKC家族的其他成员中引入了类似的改变,并测试其对共转染的活化PKC功能的影响。对于PKC家族的所有三个亚类,预测的激活环磷酸化位点的突变均导致显性负性特性。这些特性并不局限于同源的PKC同工型,而是在不同亚类中均有效。例如,两个PKCζ突变体(非典型同工型)抑制PKCα(经典同工型)和PKCε(新同工型)。对于所有这些突变体,抑制作用与阻止磷酸化PKCα积累的能力相关,这与预期的作用模式一致。就PKCα突变体而言,已表明抑制作用需要全长突变蛋白。这些结果为所有PKC同工型磷酸化过程中存在共同步骤提供了证据。